Dr. Russell Samuel Fileccia Jr., MD

Dr. Fileccia practices at CHRISTUS Highland Medical Center in Shreveport, Louisiana, part of CHRISTUS Health.

Dr. Fileccia's NPI, 1164412789, was assigned on October 25, 2005. Dr. Fileccia holds Louisiana license MD.021330.

Dr. Fileccia's primary practice is CHRISTUS Highland Medical Center, at 1453 E Bert Kouns Industrial Drive, Shreveport, LA 71105 in Caddo Parish. The practice phone is (318) 681-5000.

Dr. Fileccia's primary practice is CHRISTUS Highland Medical Center in Shreveport, Louisiana, part of CHRISTUS Health. Dr. Fileccia is also affiliated with Willis Knighton North. The medical group on file is Advanced Cardiovascular Specialists. Dmand AI also links Dr. Fileccia to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fileccia practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Fileccia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Fileccia is licensed in Louisiana.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Fileccia treats.

CMS data shows 11,677 Medicare services from Dr. Fileccia across 30 procedure codes in 2024, for 2,163 Medicare patients. Medicare paid $2,447,882 for them.

CMS counts 2,163 Medicare patients who saw Dr. Fileccia in 2024. The largest group is 65 to 74, with 989 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fileccia's median patient age at 72, with 49% women.

In 2024, Dr. Fileccia wrote 7,643 Medicare Part D claims for 842 patients. 85% of them were for generic drugs. CMS names the drug for 7,331 of them, across 67 drugs with 11 or more claims each, at $832,012 in total drug cost. In 2023, CMS named 7,352 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Fileccia for performance year 2024, reported as part of a group. Dr. Fileccia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Fileccia in 2016. Dr. Fileccia's most frequent co-authors are Ravi Dhingra, MD, MPH, Howard J. Eisen, MD and Michael Kiernan, MD.

CMS Open Payments shows 160 general payments to Dr. Fileccia from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Abbott Laboratories paid the most, $4,028.

Dmand AI lists 2 awards for Dr. Fileccia, most recently CMS Stage 1 EHR in 2013.

Dr. Fileccia is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.